Disease | epilepsy |
Phenotype | C0042373|vascular disease |
Sentences | 6 |
PubMedID- 20586732 | Objectives: the aim of the study was to investigate risk factors for cardiovascular disease in patients with epilepsy using the new antiepileptic drug levetiracetam (lev), compared with patients taking carbamazepine (cbz) or lamotrigine (ltg). |
PubMedID- 25028247 | Purpose: epilepsy is associated with increased cardiovascular disease (cvd) morbidity and mortality. |
PubMedID- 25902783 | Further, vitamin d deficiency has been demonstrated to be an important regulator in the neurocardiovascular disease pathways associated with epilepsy (scorza et al. |
PubMedID- 25503082 | Additional exclusion criteria common to both studies included significant pulmonary, gastrointestinal, metabolic (except diabetes mellitus), neurological, psychiatric or other disorders that could affect efficacy or safety assessments or compromise patient safety; significant cardiac or vascular disease; a history of seizure disorder or epilepsy; a history of mild or moderate traumatic brain injury, stroke, transient ischaemic attack or brain neoplasm within 1 year; a history of severe traumatic brain injury within 15 years; a history of malignancy within the past 2 years (except for successfully treated basal cell carcinoma); severe renal impairment; moderate or severe hepatic impairment; chronic hepatitis b or c; active hepatitis b or c within the past 3 months; severe or extensive diabetic foot ulcers, limb amputation, or charcot neuroarthropathy; a clinically relevant history of sensitivity to acetaminophen or opioid analgesics (or their ingredients); any scheduled surgery or painful procedure during the study that could affect efficacy or safety assessments; and any condition (other than painful dpn) that could confound the assessment or self-evaluation of pain (e.g. |
PubMedID- 24273498 | This association may just suggest epilepsy with concurrent cardiovascular disease, but in this young age group, it may suggest a link between the two conditions, particularly a predisposition for vasovagal hyperactivity. |
PubMedID- 23143721 | Predictors of epilepsy in children with cerebrovascular disease. |
Page: 1